Lupin has received approval from the US Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA), Meclizine Hydrochloride tablets USP, 12.5 mg, 25 mg, and 50 mg, to market a generic equivalent of Antivert Tablets, 12.5 mg, 25 mg, and 50 mg, of Casper Pharma, a statement from Lupin said.
Lupin's Generic Meclizine Hydrochloride Receives Approval in the U.S.
Enforcement Report - Week of April 6, 2022
Invagen Pharms' Generic Meclizine Hydrochloride Receives Approval in the U.S.
Enforcement Report - Week of October 13, 2021
Enforcement Report - Week of February 24, 2021
Zydus Pharms`s Generic Meclizine Hydrochloride Receives Approval in US
Drug firm Zydus Cadila on Wednesday said it has received nod from the US health regulator to market generic antihistamine Meclizine hydrochloride tablets.
Enforcement Report - Week of November 20, 2019
Enforcement Report - Week of November 22, 2017